HarrisJE. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia 1984 through 1989. JAMA1990; 263: 397–401
2.
PetersBSBeckEJColemanDG. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: The changing face of AIDS. BMJ1991; 302: 203–7
3.
FischlMARichmanDDGriecoMH. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med1987; 317: 185–91
4.
Creagh-KirkTDoiPAndrewsE. Survival experience among patients with AIDS receiving zidovudine. JAMA1988; 260: 3009–15
5.
Centers for Disease Control. HIV/AIDS Surveillance Report. Atlanta, Georgia: Centers for Disease Control; 1990:1–22
6.
HarnlyMESwanSHHollyEAKelterAPadianN.Temporal trends in the incidence of non-Hodgkin's lymphoma and selected malignancies in a population with a high incidence of acquired immune deficiency syndrome (AIDS). Am J Epidemiol1988; 128: 261–7
7.
RabkinCSBiggarRJHormJW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer1991; 47: 692–6
8.
SpectorBDPerryGSJerseyJH. Genetically determined immunodeficiency disease (GDID) and malignancy: Report from the immunodeficiency cancer registry. Clin Immunol Immunopathol1978; 11: 12–29
9.
FrizzeraGRosaiJDehnerLP. Lymphoreticular disorders in primary immunodeficiencies: New findings based on an up-to-date histologic classification of 35 cases. Cancer1980; 46: 692–9
10.
HooverRFraumeniJF. Risk of cancer in renal-transplant recipients. Lancet1973; ii: 55–7
11.
ClearyMLWarnkeRSklarJ.Monoclonality of lymphoproliferative lesions in cardiac transplant recipients: Clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med1984; 310: 477–82
12.
GossettTCGaleRCFleischmanH. Immunoblastic sarcoma in donor cell after bone marrow transplantation. N Engl J Med1979; 300: 904–7
13.
Centers for Disease Control task force on Kaposi's sarcoma. Epidemiological aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. N Engl J Med1982; 306: 248–52
14.
Centers for Disease Control. Update: Acquired immunodeficiency syndrome-United States. MMWR1982; 31: 507–14
15.
ZieglerJLBecksteadJAVolberdingPA. Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med1984; 311: 565–70
16.
LevineAMGillPSMeyerPR. Retrovirus and malignant lymphoma in homosexual men. JAMA1985; 254: 1921–5
17.
Centers for Disease Control. Revision of the case definition of acquired immunodeficiency syndrome for national reporting—United States. MMWR1985; 34: 373–5
18.
OurcyWLJakubekDJ. Multiple squamous cell carcinomas and human immunodeficiency virus infection. Ann Intern Med1987; 106: 334
19.
DalingJRWeissNSHislopTG. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med1987; 317: 973–7
20.
RellihanMADooleyDPBurkeTWBerklandMELongfieldRN. Rapidly progressing cervical cancer in a patient with human immunodeficiency virus infection. Gynecol Oncol1990; 36: 435–8
21.
zur HausenH.Human papillomaviruses in the pathogenesis of anogenital cancer. Virology1991; 184: 9–13
22.
VousdenKH. Human papillomaviruses and cervical carcinoma. Cancer Cells1989; 1: 43–50
23.
ZieglerJLMinerRCRosenbaumE. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet1982; ii: 631–3
24.
KaplanMHSusinMPahwaSG. Neoplastic complications of HTLV-III infections. Lymphomas and solid tumors. Am J Med1987; 82: 389–96
25.
KaplanLDAbramsDIFeigalE. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA1989; 261: 719–24
26.
KnowlesDChamulakGSubarM. Lymphoid neoplasia associated with the acquired immune deficiency syndrome (AIDS): The NYU experience. Ann Intern Med1988; 108: 744–53
27.
LevineAMeyerPBegandyM. Development of B-cell lymphoma in homosexual men. Clinical and immunological findings. Ann Intern Med1984; 100: 7–13
28.
KnowlesDMInghiramiGUbriacoADella-FaveraR.Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood1989; 73: 792–9
KaplanLDAbramsDAFeigalEG, Clinical course and epidemiology of Hodgkin's disease in homosexual men. III International Conference on AIDS, Washington DC, 1–5 June 1987; 9
31.
BiggarRJHormJGoedertJJMelbyeM.Cancer in the group at risk of acquired immunodeficiency syndrome (AIDS) through 1984. Am J Epidemiol1987; 126: 578–86
32.
DaarESHoDD. Immunopathogenesis of HIV-1 infection. In: GottliebMS. eds. Current Topic in AIDS, vol. 2. New York: John Wiley, 1989; 151–75
33.
EpsteinMAAchongBG. The relationship of the (Epstein-Barr) virus to Burkitt's lymphoma. In: EpsteinMAAchongBG, eds. The Epstein-Barr virus. New York: Springer-Verlag, 1979; 322–37
34.
PennI.The incidence of malignancies in transplant patients. Transplantation Proc1975; 7: 323–6
BirxDLRedfieldRRTosatoG.Defective regulation of Epstein-Barr infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med1986; 314: 874–9
37.
RinaldoCKingsleyLLyterDW. Association of HTLV-III with Epstein-Barr infection and abnormalities of T lymphocytes in homosexual men. J Infect Dis1986; 154: 556–61
38.
CrawfordDWellerIIliescuV. Epstein-Barr (EB) virus infection in homosexual men in London. Br J Vener Dis1984; 60: 258–64
39.
GreenspanJSGreenspanDLennetteE. Replication of Epstein-Barr virus in the epithelial cells of oral ‘hairy’ leukoplakia, an AIDS-associated lesion. N Engl J Med1985; 313: 1564–71
40.
YoungLSLauRRoweM. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol1991; 65: 2868–74
41.
ClearyMLDorfmanRFSklarJ.Failure in immunological control of the (Epstein-Barr) virus infection. In: EpsteinMAAchongBG, eds. The Epstein-Barr virus: recent advances. London: William Heineman, 1986; 163–81
42.
Hamilton-DutoitSJPallesenGFranzmannMB. AIDS-related lymphoma. Histopathology, Immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol1991; 138: 149–63
43.
ErnbergIAltiokE.The role of Epstein-Barr virus in lymphomas of HIV-carriers. APM1S1989; Suppl 8: 58–61
44.
SubarMNeriAInghiramiGKnowlesDMDall-FaveraR.Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood1988; 72: 667–71
45.
ZieglerJLAnderssonMKleinG. Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma. Int J Cancer1976; 17: 701–642
46.
MeekerTCShiramizuBKaplanL. Evidence for molecular subtypes of HIV-associated lymphoma: Division into peripheral monoclonal, polyclonal and central nervous system lymphoma. AIDS1991; 5: 669–74
47.
RothleinRDustinMLMartinSDSpringerTA. A human intercellular adhesion molecule (ICAM 1) distinct from LFA-1. J Immuol1986; 147: 1270–74
48.
Sanchez-MadridFKrenskyAMWareCF. Three distinct antigens associated with human T lymphocyte-mediated cytolysis: LFA-1, LFA-2 and LFA-3. Proc Natl Acad Sci USA1982; 79: 7489–92
49.
NowellPCHungerfordDA. A minute chromosome in human chronic granulocytic leukemia. Science1960; 132: 1497
50.
KurzrockRGuttermanJUTalpazM.The molecular genetics of Philadelphia chromosome-positive leukemias. N Engl J Med1988; 319: 990–8
51.
ManolovGManolovaY.Marker band in one chromosome 14 from Burkitt lymphomas. Nature1972; 237: 33–4
52.
ManolovaYManolovGLevanAKleinG.Genesis of the 14q+ marker in Burkitt's lymphoma. Hereditas1979; 90: 5–10
53.
CoryS.Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res1986; 47: 189–234
54.
PelicciP-GKnowlesDMMagrathIDalla-FaveraR.Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Natl Acad Sci1986; 83: 2984–88
55.
van LohuizenMVerbeekBScheijenBWientjensEvan der GuldenHBernsA.Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus targeting. Cell1991; 5: 737–52
56.
HauptYAlexanderWSBarriGKlinkenSPAdamsJM. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice. Cell1991; 5: 753–64
57.
AdamsJMHarrisAWPinkertCA. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature1985; 318: 533–38
KnudsonAG. Hereditary cancer, oncogenes and anti-oncogenes. Cancer Res1985; 45: 1437–43
60.
GaidanoGBalleriniPGongJZ. p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA1991; 88: 5413–17
61.
FarrellPJAllanGJShanahanFVousdenKCrookT.p53 is frequently mutated in Burkitt's lymphoma cell lines. EMBO J1991; 10: 2879–87
62.
AyersKM. Preclinical toxicology of zidovudine. An overview. Am J Med1988; 85: 186–8
63.
PludaJMYarchoanRJaffeE. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann Intern Med1990; 113: 276–82
64.
YarchoanRKleckerRWWeinholdKJ. Administration of 3‘-azido-3’-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex. Lancet1986; i: 575–80
BalasubramanyamAWaxmanMKazalHLLeeMH. Malignant lymphoma of the heart in acquired immunodeficiency syndrome. Chest1986; 90: 243–6
67.
Pivetti-PezziPTamburiSGastaldiR. Ocular involvement in AIDS-associated lymphomas. VII International Conference on AIDS, Florence, June1991; 1: 282(abs. M.B.2400)
68.
GreenTLEversoleLR. Oral lymphomas in HIV-infected patients: Association with Epstein-Barr virus DNA. Oral Surg Oral Med Oral Pathol1989; 67: 437–42
69.
KahnDGRothmanPWeismanJ.Urethral lymphoma as the initial manifestation of AIDS. VII International Conference on AIDS, Florence, June1991; l: 279(abs. M. B.2388)
70.
GillPSGrahamRABoswellW. A comparison of imaging, clinical and pathologic aspects of space-occupying lesions within the brain in patients with AIDS. Am J Physiol1986; 1: 134–41
71.
RemickSCDiamondCMigliozziJA. Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. Medicine1990; 69: 345–60
72.
LevyRMRosenbloomSPerrettLV. Neuroradiological findings in AIDS: A review of 200 cases. Am J Radiol1986; 147: 977–83
73.
CiricilloSFRosenblumML. Use of CT and MR imaging to distinguish intracranial lesions and to define the need for biopsy in AIDS patients. J Neurosurg1990; 73: 720–4
74.
KupferMCZeeCSCollettiPMBoswellWDRhodesR.MRI evaluation of AIDS-related encephalopathy: Toxoplasmosis vs. lymphoma. Magn Reson Imaging1990; 8: 51–7
75.
LiC-YWitzigTEPhylikyRL. Diagnosis of B-cell non-Hodgkin's lymphoma of the central nervous system by immunocytochemical analysis of cerebrospinal fluid lymphocytes. Cancer1986; 20: 566–72
76.
PresantCABlayneyDProffittRT. Preliminary report: Imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes. Lancet1990; 335: 1307–9
DeWeeseTLHazukaMBHommelDJKinzieJJDanielWE. AIDS-related non-Hodgkin's lymphoma: The outcome and efficacy of radiation therapy. Int J Radiat Oncol Biol Phys1991; 20: 803–8
GroopmanJE. Management of the hematologic complications of human immunodeficiency virus infection. Rev Infect Dis1990; 12: 931–7
81.
HahnSMPludaJLietzauJ. Treatment of AIDS-related non-Hodgkin's lymphoma (NHL) with chemotherapy, AZT, and granulocyte-macrophage colony stimulating factor (GM-CSF). VII International Conference on AIDS, Florence, June1991; 2: 274 (abs. W.B.2368)
82.
SoaveRJohnsonWDJr. AIDS Commentary: Cryptosporidium and Isospora belli infections. J Infect Dis1988; 157: 225–9
83.
FuchsDJagerHPopescuM. Immune activation markers to predict AIDS and HIV-1 survival. Immunol Lett1990; 26: 75–9
84.
MazzaPBocchiaMTumiettioF. rIL-2 in the treatment of lymphomas associated to HIV infection. Preliminary report. VII International Conference on AIDS, Florence, June1991; 2: 274 (abs. W. B. 2369)
85.
Anon. Interleukin-2: Sunrise for immunotherapy?Lancet1989; i: 308